{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:01Z","timestamp":1786997641638,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:00:00Z","timestamp":1611705600000},"content-version":"am","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006586","name":"Centre Hospitalier Universitaire de Nice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.transproceed.2019.11.002","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T17:46:46Z","timestamp":1577468806000},"page":"204-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+\/R\u2212): A Case Series"],"prefix":"10.1016","volume":"52","author":[{"given":"Marine","family":"Andreani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Benzaken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Cassuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Jeribi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Caramella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Giordanengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Esnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Seitz-Polski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.11.002_bib1","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib2","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib3","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2019.11.002_bib4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib5","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1097\/TP.0b013e3181ff1493","article-title":"Extended valganciclovir prophylaxis in D+\/R\u2212 kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study","volume":"90","author":"Humar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib7","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2019.11.002_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043937","article-title":"An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients","volume":"7","author":"Egli","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.transproceed.2019.11.002_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/TP.0b013e31823c1cd4","article-title":"clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia","volume":"93","author":"Lisboa","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.transproceed.2019.11.002_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10875-005-5372-8","article-title":"T\u00a0cell control of primary and latent cytomegalovirus infections in healthy subjects","volume":"25","author":"Lidehall","year":"2005","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.transproceed.2019.11.002_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of human cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.transproceed.2019.11.002_bib14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/TP.0b013e3182115ba2","article-title":"Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment","volume":"91","author":"Benmarzouk-Hidalgo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib15","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.1128\/JVI.00581-07","article-title":"Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response","volume":"81","author":"Crough","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.transproceed.2019.11.002_bib16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1600-6143.2008.02191.x","article-title":"Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation","volume":"8","author":"Mattes","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1586\/erm.10.109","article-title":"QuantiFERON-CMV assay for the assessment of cytomegalovirus cell-mediated immunity","volume":"11","author":"Giulieri","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.transproceed.2019.11.002_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1399-3062.2006.00199.x","article-title":"Ex\u00a0vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV","volume":"9","author":"Walker","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2019.11.002_bib19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2019.11.002_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-6143.2005.01207.x","article-title":"American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation","volume":"6","author":"Humar","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib23","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/ajt.14347","article-title":"An interventional study using cell-mediated immunity to personalize therapy for cytomegalovirus infection after transplantation","volume":"17","author":"Kumar","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.11.002_bib24","series-title":"Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays","author":"Fryer","year":"2010"},{"key":"10.1016\/j.transproceed.2019.11.002_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12879-018-3075-z","article-title":"Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients","volume":"18","author":"Deborska-Materkowska","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.transproceed.2019.11.002_bib26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/TP.0b013e31822fa4b7","article-title":"Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients","volume":"92","author":"Lisboa","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib27","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1128\/JCM.00563-13","article-title":"Comparison of cytomegalovirus (CMV) enzyme-linked immunosorbent spot and CMV QuantiFERON gamma interferon-releasing assays in assessing risk of CMV infection in kidney transplant recipients","volume":"51","author":"Abate","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.transproceed.2019.11.002_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/TP.0b013e318239e90c","article-title":"Kinetics of T-lymphocyte subsets and posttransplant opportunistic infections in heart and kidney transplant recipients","volume":"93","author":"Calarota","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.11.002_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s12088-012-0268-9","article-title":"Cytomegalovirus disease in renal transplant recipients: a single-center experience","volume":"52","author":"Bhadauria","year":"2012","journal-title":"Indian J Microbiol"},{"key":"10.1016\/j.transproceed.2019.11.002_bib30","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.transproceed.2012.04.036","article-title":"Six-month low-dose valganciclovir prophylaxis in cytomegalovirus D+\/R- kidney transplant patients receiving thymoglobulin induction","volume":"45","author":"Luan","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2019.11.002_bib31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1086\/597089","article-title":"Infectious complications of antilymphocyte therapies in solid organ transplantation","volume":"48","author":"Issa","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transproceed.2019.11.002_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.antiviral.2016.06.012","article-title":"Prevention strategies differentially modulate the impact of cytomegalovirus replication on CD8(+) T-cell differentiation in high-risk solid organ transplant patients","volume":"132","author":"Cantis\u00e1n","year":"2016","journal-title":"Antiviral Res"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519303148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134519303148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:34:20Z","timestamp":1758576860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134519303148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0041134519303148"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.11.002","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring of CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients With a High Risk of CMV Disease (D+\/R\u2212): A Case Series","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}